Latest Wearables News

dorsaVi has secured a three-year agreement with SANO Health to deploy its ViSafe+ wearable sensor technology across remote mining sites, reinforcing its foothold in high-risk occupational health sectors.

Nanoveu’s subsidiary EMASS has hit a key milestone with its ECS-DoT chip achieving 50 updates per second in drone flight simulations, enabling smarter, more stable drones with up to 30% longer flight times.

Catapult Group International Ltd reported a 16.5% increase in revenue to $116.5 million for FY25, driven by strong subscription growth and improved operational efficiency. The company narrowed its net loss after tax to $8.8 million, signaling progress in its global sports technology strategy.

Spacetalk Ltd reports robust 3QFY25 results, showcasing strong revenue growth and a sharp reduction in losses as it pivots to a subscription-driven family safety platform.

Nanoveu’s subsidiary EMASS has launched real-world trials of its ECS-DoT AI chip, aiming to extend drone flight times by up to 30% while enabling advanced onboard intelligence with ultra-low power consumption.

Bio-Gene Technology Limited is progressing its development of two novel insecticidal compounds, Qcide and Flavocide, targeting major global markets with strong commercial validation and significant US Department of Defense funding.

Andromeda Metals has successfully produced ultra-high purity alumina (HPA) at 99.9985% purity using a novel, cost-effective, and lower carbon process from kaolin sourced at its Great White Project. Independent validation confirms the breakthrough, positioning the company to capitalize on growing global demand.

Mighty Kingdom Limited reports a positive operating cash inflow and significant cost reductions in Q3 FY25, alongside leadership changes and a $3.35 million capital raise underway to fuel growth.

Nanoveu Limited has completed its strategic acquisition of EMASS, advancing its foothold in ultra-low-power AI-driven edge computing. The company also strengthened its leadership team and secured additional capital to fuel growth.

dorsaVi’s Q3 FY25 report reveals growing adoption of its AI-powered video movement analysis in the US, a new elite athlete research partnership, and the launch of a pioneering 3D ACL injury prevention test.

Bio-Gene Technology Limited has been awarded two significant grants totaling A$3 million by the US Department of Defense, validating its innovative insecticide technologies Flavocide® and Qcide®. The company is advancing regulatory filings and scaling production to target both military and civilian markets.

BrainChip Holdings advanced its neuromorphic AI technology through significant contracts with the Swedish National Space Agency and the U.S. Air Force, while exploring a potential redomiciling to the US. The company reported steady cash outflows and ongoing strategic partnerships.